Evidence map›Paper›PMID 29493577›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2018

Mosaic maternal 10qter deletions are associated with FRA10B expansions and may cause false-positive noninvasive prenatal screening results.

Karin Huijsdens-van Amsterdam, Roy Straver, Merel C van Maarle, Alida C Knegt, Diane Van Opstal, Frank Sleutels, Dominique Smeets, Erik A Sistermans

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Genome-wide cell-free DNA screening: a focus on copy-number variants.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Karin Huijsdens-van AmsterdamDepartment of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands.
Roy StraverDepartment of Clinical Genetics, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
Merel C van MaarleDepartment of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands.
Alida C KnegtDepartment of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands.
Diane Van OpstalDepartment of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
Frank SleutelsDepartment of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
Dominique SmeetsDepartment of Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Erik A SistermansDepartment of Clinical Genetics, VU University Medical Center Amsterdam, Amsterdam, The Netherlands. e.sistermans@vumc.nl.
Amsterdam UMC Location University of Amsterdam · NLAmsterdam UMC Location Vrije Universiteit Amsterdam · NLErasmus MC · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeUsing genome-wide noninvasive prenatal screening (NIPS), we detected a 20-megabase specific deletion starting at 10q25 in eight pregnancies. The deletion could not be confirmed by invasive testing. Since all 10(q25→qter) deletions started close to the FRA10B fragile site in 10q25, we investigated whether the pregnant women were indeed carriers of FRA10B.

methodsWe performed NIPS analysis for all autosomes using single-read sequencing. Analysis was done with the WISECONDOR algorithm. Culture of blood lymphocytes with bromodeoxyuridine was used to detect FRA10B expansions. Fluorescence in situ hybridization and array analysis were used to find maternal and/or fetal deletions.

resultsWe confirmed the presence of a FRA10B expansion in all four tested mothers. Fluorescence in situ hybridization and array analysis confirmed the presence of a maternal mosaic deletion of 10(q25→qter).

conclusionThe recurring 10(q25→qter) deletion detected with NIPS is a false-positive result caused by a maternal low-level mosaic deletion associated with FRA10B expansions. This has important consequences for clinical follow-up, as invasive procedures are unnecessary. Expanded maternal FRA10B repeats should be added to the growing group of variants in the maternal genome that may cause false-positive NIPS results.

Indexed as

AdultChromosome DeletionChromosome Fragile SitesChromosomes, Human, Pair 10FemaleFetusGenetic TestingGenome, HumanHumansIn Situ Hybridization, FluorescencePregnancyPrenatal DiagnosisSequence DeletionTrisomyfalse-positive resultsFRA10Bfragile sitesNIPSnoninvasive prenatal screening

Identifiers

PMID29493577
OpenAlexW2794401479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.